US EditionPublished • loading... • Updated
Exploring Growth Trends in the Chemotherapy Induced Anemia Market: A Surge to USD 4.84 Billion by 2032
Summary by dailyguardian.ca
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Exploring Growth Trends in the Chemotherapy Induced Anemia Market: A Surge to USD 4.84 Billion by 2032
Dublin, Dec. 16, 2025 (GLOBE NEWSWIRE) — The “Chemotherapy Induced Anemia Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. The chemotherapy induced anemia market grew from USD 2.70 billion in 2024 to USD 2.90 billion in 2025 and is set to reach USD 4.84 billion by 2032, registering a CAGR of 7.57% over the forecast period. Market expansion is fueled by rising cancer incidence, greater adoption of erythropo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
